title: Letter from Konstantinos P. Letsas et al. - invited editorial comment.
authors.forename: John
authors.initials: J
authors.lastname: Somberg
authors.forename: Janos
authors.initials: J
authors.lastname: Molnar
mesh_terms: D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008133:Long QT Syndrome / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D016171:Torsades de Pointes / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000139:chemically induced; D000077334:Zolpidem
chemical_list: D000889:Anti-Arrhythmia Agents; D006993:Hypnotics and Sedatives; D011725:Pyridines; D000077334:Zolpidem; D000638:Amiodarone